Chlorambucil-induced cytomegalovirus infection: a case report

J Med Case Rep. 2014 Aug 20:8:280. doi: 10.1186/1752-1947-8-280.

Abstract

Introduction: Chlorambucil is an alkylating agent used in combination with prednisolone for the treatment of idiopathic membranous nephropathy. Although chlorambucil is generally well-tolerated, it is a myelosuppresive drug that can cause several infections.

Case presentation: We report the case of an 81-year-old Caucasian male presenting with idiopathic membranous nephropathy who developed fever, cough, dyspnea, pulmonary infiltrates, and abdominal pain shortly after the initiation of treatment with chlorambucil and corticosteroids for nephropathy. Virology tests for infectious diseases revealed a recent cytomegalovirus infection. Antiviral treatment (ganciclovir) resulted in full remission.

Conclusions: Cytomegalovirus infection should be considered in the differential diagnosis of respiratory symptoms and pulmonary infiltrates in patients treated with chlorambucil for nephrotic syndrome.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Alkylating Agents / adverse effects*
  • Alkylating Agents / therapeutic use
  • Chlorambucil / adverse effects*
  • Chlorambucil / therapeutic use
  • Cytomegalovirus Infections / chemically induced*
  • Cytomegalovirus Infections / diagnosis
  • Glomerulonephritis, Membranous / drug therapy
  • Humans
  • Male

Substances

  • Alkylating Agents
  • Chlorambucil